| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |